2-(4,4-Dimethyl-1-cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

4,5-Dibromo-1H-imidazole, 95.0%, 25g

5-Methylthiophene-2-carbonitrile>98.0%(GC)1g

2-((tert-Butoxycarbonyl)amino)isonicotinic acid, 95.0%, 5g

2-Chlorocyclododecan-1-one, 97%, 1g

2-amino-6-methoxypyridine-3,5-dicarbonitrile, 95.0%, 500mg

5-hydroxy-1,2-dimethyl-4(1H)-pyridinone, 95.0%, 1g

2-(4,6-Dimethyl-pyrimidin-2-ylsulfanyl)-propionic acid, 95.0%, 1g

Di(pyridin-3-yl)methanone, 95.0%, 5g

(S)-1-(3-NITROPHENYL)ETHANAMINE, 95.0%, 250mg

iScope IS.1152-PLPHi Biocular mit Planphase-IOS-Objektiven und Rackless-Kreuztisch (unendlich)

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

3-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid, 97.0%, 5g